Persons with dispensed medicines; age and sex
Sex | Ages | Medicine group (ATC) | Periods | Persons with dispensed medicines (number) | Persons with medicines, relative (%) |
---|---|---|---|---|---|
Total male and female | Total age | A04 Antiemetics and antinauseants | 2021* | 109,225 | 0.61 |
Total male and female | Total age | A04A Antiemetics and antinauseants | 2021* | 109,225 | 0.61 |
Total male and female | Total age | A10 Drugs used in diabetes | 2021* | 848,950 | 4.74 |
Total male and female | Total age | A10X Other drugs used in diabetes | 2021* | 0 | 0.00 |
Total male and female | Total age | A14 Anabolic agents for systemic use | 2021* | 400 | 0.00 |
Total male and female | Total age | C01D Vasodilators used in card. diseases | 2021* | 253,040 | 1.41 |
Total male and female | Total age | D01 Antifungals for dermatological use | 2021* | 762,635 | 4.26 |
Total male and female | Total age | D01A Antifungals for topical use | 2021* | 701,815 | 3.92 |
Total male and female | Total age | D01B Antifungals for systemic use | 2021* | 77,340 | 0.43 |
Total male and female | Total age | D05A Antipsoriatics for topical use | 2021* | 83,965 | 0.47 |
Total male and female | Total age | D05B Antipsoriatics for systemic use | 2021* | 3,795 | 0.02 |
Total male and female | Total age | D06 Antibiotics.. for dermatological use | 2021* | 684,235 | 3.82 |
Total male and female | Total age | D06A Antibiotics for topical use | 2021* | 561,225 | 3.13 |
Total male and female | Total age | D06B Chemotherapeutics for topical use | 2021* | 134,795 | 0.75 |
Total male and female | Total age | D10A Anti-acne preparations, topical use | 2021* | 163,490 | 0.91 |
Total male and female | Total age | D10B Anti-acne preparations,systemic use | 2021* | 32,070 | 0.18 |
Total male and female | Total age | G02B Contraceptives for topical use | 2021* | 18,730 | 0.10 |
Total male and female | Total age | G03A Hormonal contraceptives system. use | 2021* | 324,310 | 1.81 |
Total male and female | Total age | H02 Corticosteroids for systemic use | 2021* | 793,840 | 4.43 |
Total male and female | Total age | H02A Corticosteroids system.use, plain | 2021* | 785,225 | 4.38 |
Total male and female | Total age | H02B Corticosteroids system.use, combi. | 2021* | 10,715 | 0.06 |
Total male and female | Total age | J General antiinfectives for system.use | 2021* | 3,089,290 | 17.25 |
Total male and female | Total age | J01 Antibacterials for systemic use | 2021* | 2,834,430 | 15.83 |
Total male and female | Total age | J02 Antimycotics for systemic use | 2021* | 142,630 | 0.80 |
Total male and female | Total age | J02A Antimycotics for systemic use | 2021* | 142,630 | 0.80 |
Total male and female | Total age | J05 Antivirals for systemic use | 2021* | 115,510 | 0.65 |
Total male and female | Total age | N07B Drugs used in addictive disorders | 2021* | 57,425 | 0.32 |
Total male and female | Total age | R01B Nasal decongestants, systemic use | 2021* | 0 | 0.00 |
Total male and female | Total age | R03C Adrenergics for systemic use | 2021* | 65 | 0.00 |
Total male and female | Total age | R06 Antihistamines for systemic use | 2021* | 1,363,980 | 7.62 |
Total male and female | Total age | R06A Antihistamines for systemic use | 2021* | 1,363,980 | 7.62 |
Total male and female | 0 to 15 years | A04 Antiemetics and antinauseants | 2021* | 22,925 | 0.84 |
Total male and female | 0 to 15 years | A04A Antiemetics and antinauseants | 2021* | 22,925 | 0.84 |
Total male and female | 0 to 15 years | A10 Drugs used in diabetes | 2021* | 4,150 | 0.15 |
Total male and female | 0 to 15 years | A10X Other drugs used in diabetes | 2021* | 0 | 0.00 |
Total male and female | 0 to 15 years | A14 Anabolic agents for systemic use | 2021* | 0 | 0.00 |
Total male and female | 0 to 15 years | C01D Vasodilators used in card. diseases | 2021* | 0 | 0.00 |
Total male and female | 0 to 15 years | D01 Antifungals for dermatological use | 2021* | 72,695 | 2.66 |
Total male and female | 0 to 15 years | D01A Antifungals for topical use | 2021* | 71,140 | 2.61 |
Total male and female | 0 to 15 years | D01B Antifungals for systemic use | 2021* | 2,370 | 0.09 |
Total male and female | 0 to 15 years | D05A Antipsoriatics for topical use | 2021* | 2,350 | 0.09 |
Total male and female | 0 to 15 years | D05B Antipsoriatics for systemic use | 2021* | 15 | 0.00 |
Total male and female | 0 to 15 years | D06 Antibiotics.. for dermatological use | 2021* | 168,010 | 6.16 |
Total male and female | 0 to 15 years | D06A Antibiotics for topical use | 2021* | 165,590 | 6.07 |
Total male and female | 0 to 15 years | D06B Chemotherapeutics for topical use | 2021* | 2,995 | 0.11 |
Total male and female | 0 to 15 years | D10A Anti-acne preparations, topical use | 2021* | 10,170 | 0.37 |
Total male and female | 0 to 15 years | D10B Anti-acne preparations,systemic use | 2021* | 810 | 0.03 |
Total male and female | 0 to 15 years | G02B Contraceptives for topical use | 2021* | 50 | 0.00 |
Total male and female | 0 to 15 years | G03A Hormonal contraceptives system. use | 2021* | 14,115 | 0.52 |
Total male and female | 0 to 15 years | H02 Corticosteroids for systemic use | 2021* | 20,545 | 0.75 |
Total male and female | 0 to 15 years | H02A Corticosteroids system.use, plain | 2021* | 20,540 | 0.75 |
Total male and female | 0 to 15 years | H02B Corticosteroids system.use, combi. | 2021* | 5 | 0.00 |
Total male and female | 0 to 15 years | J General antiinfectives for system.use | 2021* | 298,285 | 10.93 |
Total male and female | 0 to 15 years | J01 Antibacterials for systemic use | 2021* | 292,715 | 10.73 |
Total male and female | 0 to 15 years | J02 Antimycotics for systemic use | 2021* | 2,515 | 0.09 |
Total male and female | 0 to 15 years | J02A Antimycotics for systemic use | 2021* | 2,515 | 0.09 |
Total male and female | 0 to 15 years | J05 Antivirals for systemic use | 2021* | 1,440 | 0.05 |
Total male and female | 0 to 15 years | N07B Drugs used in addictive disorders | 2021* | 25 | 0.00 |
Total male and female | 0 to 15 years | R01B Nasal decongestants, systemic use | 2021* | 0 | 0.00 |
Total male and female | 0 to 15 years | R03C Adrenergics for systemic use | 2021* | 5 | 0.00 |
Total male and female | 0 to 15 years | R06 Antihistamines for systemic use | 2021* | 186,920 | 6.85 |
Total male and female | 0 to 15 years | R06A Antihistamines for systemic use | 2021* | 186,920 | 6.85 |
Total male and female | 15 to 25 years | A04 Antiemetics and antinauseants | 2021* | 6,680 | 0.31 |
Total male and female | 15 to 25 years | A04A Antiemetics and antinauseants | 2021* | 6,680 | 0.31 |
Total male and female | 15 to 25 years | A10 Drugs used in diabetes | 2021* | 10,860 | 0.50 |
Total male and female | 15 to 25 years | A10X Other drugs used in diabetes | 2021* | 0 | 0.00 |
Total male and female | 15 to 25 years | A14 Anabolic agents for systemic use | 2021* | 10 | 0.00 |
Total male and female | 15 to 25 years | C01D Vasodilators used in card. diseases | 2021* | 60 | 0.00 |
Total male and female | 15 to 25 years | D01 Antifungals for dermatological use | 2021* | 76,580 | 3.50 |
Total male and female | 15 to 25 years | D01A Antifungals for topical use | 2021* | 69,665 | 3.18 |
Total male and female | 15 to 25 years | D01B Antifungals for systemic use | 2021* | 8,515 | 0.39 |
Total male and female | 15 to 25 years | D05A Antipsoriatics for topical use | 2021* | 4,670 | 0.21 |
Total male and female | 15 to 25 years | D05B Antipsoriatics for systemic use | 2021* | 70 | 0.00 |
Total male and female | 15 to 25 years | D06 Antibiotics.. for dermatological use | 2021* | 72,680 | 3.32 |
Total male and female | 15 to 25 years | D06A Antibiotics for topical use | 2021* | 59,530 | 2.72 |
Total male and female | 15 to 25 years | D06B Chemotherapeutics for topical use | 2021* | 14,305 | 0.65 |
Total male and female | 15 to 25 years | D10A Anti-acne preparations, topical use | 2021* | 68,240 | 3.12 |
Total male and female | 15 to 25 years | D10B Anti-acne preparations,systemic use | 2021* | 19,220 | 0.88 |
Total male and female | 15 to 25 years | G02B Contraceptives for topical use | 2021* | 18,625 | 0.85 |
Total male and female | 15 to 25 years | G03A Hormonal contraceptives system. use | 2021* | 309,595 | 14.15 |
Total male and female | 15 to 25 years | H02 Corticosteroids for systemic use | 2021* | 20,795 | 0.95 |
Total male and female | 15 to 25 years | H02A Corticosteroids system.use, plain | 2021* | 20,740 | 0.95 |
Total male and female | 15 to 25 years | H02B Corticosteroids system.use, combi. | 2021* | 65 | 0.00 |
Total male and female | 15 to 25 years | J General antiinfectives for system.use | 2021* | 297,360 | 13.59 |
Total male and female | 15 to 25 years | J01 Antibacterials for systemic use | 2021* | 268,310 | 12.26 |
Total male and female | 15 to 25 years | J02 Antimycotics for systemic use | 2021* | 19,210 | 0.88 |
Total male and female | 15 to 25 years | J02A Antimycotics for systemic use | 2021* | 19,210 | 0.88 |
Total male and female | 15 to 25 years | J05 Antivirals for systemic use | 2021* | 7,955 | 0.36 |
Total male and female | 15 to 25 years | N07B Drugs used in addictive disorders | 2021* | 1,260 | 0.06 |
Total male and female | 15 to 25 years | R01B Nasal decongestants, systemic use | 2021* | 0 | 0.00 |
Total male and female | 15 to 25 years | R03C Adrenergics for systemic use | 2021* | 0 | 0.00 |
Total male and female | 15 to 25 years | R06 Antihistamines for systemic use | 2021* | 193,850 | 8.86 |
Total male and female | 15 to 25 years | R06A Antihistamines for systemic use | 2021* | 193,850 | 8.86 |
Total male and female | 25 to 35 years | A04 Antiemetics and antinauseants | 2021* | 7,365 | 0.32 |
Total male and female | 25 to 35 years | A04A Antiemetics and antinauseants | 2021* | 7,365 | 0.32 |
Total male and female | 25 to 35 years | A10 Drugs used in diabetes | 2021* | 18,895 | 0.81 |
Total male and female | 25 to 35 years | A10X Other drugs used in diabetes | 2021* | 0 | 0.00 |
Total male and female | 25 to 35 years | A14 Anabolic agents for systemic use | 2021* | 20 | 0.00 |
Total male and female | 25 to 35 years | C01D Vasodilators used in card. diseases | 2021* | 380 | 0.02 |
Total male and female | 25 to 35 years | D01 Antifungals for dermatological use | 2021* | 93,955 | 4.03 |
Source: CBS. |
Dataset is not available.
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Personal Records Database (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
Data are broken down by medicine group, age and sex.
Data available from: 2006
Status of the figures:
Figures for 2020 and 2021 are provisional.
Changes as of December 9, 2022:
- The table has been expanded with information about the number of Defined Daily Doses (DDDs) provided.
- Provisional figures for 2020 (DDDs) and 2021 (all subjects) have been added.
When will new figures be published?
New figures will be published in the last quarter of 2023.
Description topics
- Persons with dispensed medicines
- Number of persons registered in the Basic Registration of Persons (BRP) in the year concerned to whom medicines are dispensed in that year that are reimbursed under the statutory basic medical insurance.
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.